A Phase 4, Randomized, Open-label Trial Evaluating the Safety, Tolerability, and Immunogenicity of DTaP Vaccine in Healthy Infants Given With a 7-valent Pneumococcal Conjugate Vaccine in Japan.

Trial Profile

A Phase 4, Randomized, Open-label Trial Evaluating the Safety, Tolerability, and Immunogenicity of DTaP Vaccine in Healthy Infants Given With a 7-valent Pneumococcal Conjugate Vaccine in Japan.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jan 2013

At a glance

  • Drugs DTaP vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Diphtheria; Pertussis; Pneumococcal infections; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Mar 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Actual patient number is 321 according to ClinicalTrials.gov.
    • 26 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top